Assessment of the anti-allodynic efficacy of a glycine transporter 2 inhibitor relative to pregabalin and duloxetine in a rat model of prostate cancer-induced bone pain-Reference-Cited by-同舟云学术

Assessment of the anti-allodynic efficacy of a glycine transporter 2 inhibitor relative to pregabalin and duloxetine in a rat model of prostate cancer-induced bone pain

Published:2020-07-26 Issue:5 Volume:72 Page:1418-1425
ISSN:1734-1140
Container-title:Pharmacological Reports
language:en
Short-container-title:Pharmacol. Rep

Author:

Imam Mohammad Zafar^ORCID,Kuo Andy^ORCID,Nicholson Janet R.,Corradini Laura,Smith Maree T.^ORCID

Funder

Australian Research Council

Boehringer Ingelheim Pharma GmbH & Co. KG

Queensland Government Smart State Research Facilities Programme

Therapeutic Innovation Australia

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s43440-020-00145-8.pdf

Reference15 articles.

1. Muralidharan A, Smith MT. Pathobiology and management of prostate cancer-induced bone pain: recent insights and future treatments. Inflammopharmacology. 2013;21:339–63.

2. Cavalli E, Mammana S, Nicoletti F, Bramanti P, Mazzon E. The neuropathic pain: An overview of the current treatment and future therapeutic approaches. Int J Immunopathol Pharmacol. 2019;33:1–10.

3. Al-Khrasani M, Mohammadzadeh A, Balogh M, Kiraly K, Barsi S, Hajnal B, et al. Glycine transporter inhibitors: A new avenue for managing neuropathic pain. Brain Res Bull. 2019;152:143–58.

4. Winters BL, Rawling T, Vandenberg RJ, Christie MJ, Bhola RF, Imlach WL. Activity of novel lipid glycine transporter inhibitors on synaptic signalling in the dorsal horn of the spinal cord. Br J Pharmacol. 2018;175:2337–47.

5. Vandenberg RJ, Ryan RM, Carland JE, Imlach WL, Christie MJ. Glycine transport inhibitors for the treatment of pain. Trends Pharmacol Sci. 2014;35:423–30.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nonopioid analgesics discovery and the Valley of Death: EMA401 from concept to clinical trial;Pain;2022-08-11

2. Glycinergic Modulation of Pain in Behavioral Animal Models;Frontiers in Pharmacology;2022-05-25

3. Assessment of the Anti-Allodynic and Anti-Hyperalgesic Efficacy of a Glycine Transporter 2 Inhibitor Relative to Pregabalin, Duloxetine and Indomethacin in a Rat Model of Cisplatin-Induced Peripheral Neuropathy;Biomolecules;2021-06-24

4. Inhibition of Glycine Re-Uptake: A Potential Approach for Treating Pain by Augmenting Glycine-Mediated Spinal Neurotransmission and Blunting Central Nociceptive Signaling;Biomolecules;2021-06-10

5. Pharmacological Evidence on Augmented Antiallodynia Following Systemic Co-Treatment with GlyT-1 and GlyT-2 Inhibitors in Rat Neuropathic Pain Model;International Journal of Molecular Sciences;2021-03-01